Structure - Function Analysis of the Cytochromes P450, Responsible for Phenprocoumon Metabolism
DOI:
https://doi.org/10.29356/jmcs.v61i4.466Keywords:
CYP450, CYP2C9, Structure-Function Relationship, Molecular Mechanics, Phenprocoumon, Docking, regioselectivityAbstract
Phenprocoumon is an oral anticoagulant used for the prophylaxis and treatment of disorders due to thrombosis. However, if oral anticoagulants are not metabolized, they could exacerbate and generate clotting disorders. Phenprocoumon is metabolized by at least four hepatic enzymes members of the cytochromes P450 family; three of which are members of the same subfamily (CYP2C9, CYP2C19 and CYP2C8). Even with too many differences in their amino acid sequence and tertiary structures, CYP2C9 and CYP3A4 have the most similar metabolic activity on phenprocoumon. In this study, we were able to explain these activity similarities using force fields of molecular mechanics for geometry and energy optimization in combination with docking techniques. The results were compared to study Structure-Function Relationships (SFR) of our four target proteins (CYP2C9, CYP2C19, CYP2C8 and CYP3A4). The study and prediction of metabolism and sites of metabolisms of drugs was successfully performed using this approach.Downloads
References
Gonzalez, F. J.; Tukey, R. H., in: The Pharmacological Basis of Therapeutics, 11 Ed., McGraw-Hill, New York, 2006, 71-91.
Wöll, S.; Kim, S. H.; Greten, H. J.; Efferth, T. Nat Prod Bioprospect, 2013, 1-7.
Brodie, E. D.; Ridenhour, B. J.; Brodie, E. D. Evolution, 2002, 56, 2067-2082.
Handschin, C.; Meyer, U. A. Pharmacol. Rev, 2003, 55, 649-673.
Bello, M.; Mendieta-Wejebe, J. E.; Correa-Basurto, J. Biochem Pharmacol, 2014, 90, 145-158.
Mendieta-Wejebe, E. J.; Correa-Basurto, J.; Garcia-Segovia, E. M.; Ceballos-Cancino, G.; Rosales-Hernandez, M. C. Curr Drug Metab, 2011, 12, 533-548.
Mendieta-Wejebe, J. E.; Rosales-Hernández, M. C.; Rios, H.; Trujillo-Ferrara, J.; López-Pérez, G.; Tamay-Cach, F.; Ramos-Morales, R.; Correa-Basurto, J. J Mol Model, 2008, 14, 537-545.
Rosales-Hernández, M. C.; Mendieta-Wejebe, J. E.; Trujillo-Ferrara, J. G.; Correa-Basurto, V. Eur. J. Med. Chem, 2010, 45, 4845-4855.
Vedani, A.; Smiesko, M. Altern Lab Anim, 2009, 37, 477-496.
Vedani, A.; Dobler M.; Smieško, M. Toxicol Appl Pharmacol, 2012, 261, 142-153.
Zaretzki, J.; Bergeron, C.; Rydberg, P.; Huang, T. W.; Bennett, K. P.; Breneman, C. M. J. Chem. Inf. Model, 2011, 51, 1667-1689.
Martínez-Sotres C.; Rutiaga-Quiñones J. G.; Herrera-Bucio, R.; Gallo, M.; López-Albarrán, P. Wood Sci. Technol, 2015, 49, 857-868.
Wester, M. R.; Johnson, E. F.; Marques-Soares, C.; Dijols, S.; Dansette, P. M.; Mansuy, D.; Stout, C. D. Biochemistry, 2003, 42, 9335-9345.
Scott, E. E.; White, M. A.; He, Y. A.; Johnson, E. F.; Stout, C. D.; Halpert, J. R. J. Biol. Chem, 2004, 279, 27294-27301.
Van Booven, D.; Marsh, S.; McLeod, H.; Carrillo, M. W.; Sangkuhl, K.; Klein, T. E.; Altman, R. B. Pharmacogenet Genomics, 2010, 20, 277.
Pirmohamed, M.; Park, B. K. Toxicology, 2003, 192, 23-32.
Lee, C. R.; Goldstein, J. A.; Pieper, J. A. Pharmacogenet Genomics, 2002, 12, 251-263.
Ufer, M.; Kammerer, B.; Kahlich, R.; Kirchheiner, J.; Yasar, Ü.; Brockmöller, J.; Rane, A. Xenobiotica, 2004, 34, 847-859.
Hirsh, J; Dalen, J. E.; Anderson, D. R.; Poller, L.; Bussey, H.; Ansell, J.; Deykin, D. Chest, 2001, 119, 8S-21S.
He, M.; Korzekwa, K. R.; Jones, J. P.; Rettie, A. E.; Trager, W. F. Arch. Biochem. Biophys, 1999, 372, 16-28.
Remko, M.; Broer, R.; Remková, A. RSC Adv., 2014, 4, 8072-8084.
van Leeuwen, Y. in Towards Improvement, Ed. Gildeprint, 2009.
Ufer, M.; Svensson, J. O.; Krausz, K. W.; Gelboin, H. V.; Rane, A.; Tybring, G. Eur. J. Clin. Pharmacol, 2004, 60, 173-182.
Kammerer, B.; Kahlich, R.; Ufer, M.; Schenkel, A.; Laufer, S.; Gleiter, C. H. Anal Bioanal Chem, 2005, 383, 909-917.
Kirchheiner, J.; Ufer, M.; Walter, E. C.; Kammerer, B.; Kahlich, R.; Meisel, C.; Schwab, M.; Gleiter, C. H.; Rane, A.; Roots, I.; Brockmöller, J. Pharmacogenet Genomics, 2004, 14, 19-26.
Kirchmair, J.; Williamson, M. J.; Tyzack, J. D.; Tan, L.; Bond, P. J.; Bender, A.; Glen, R. C. J. Chem. Inf. Model, 2012, 52, 617-648.
Nabuurs, S. B.; Wagener, M.; De Vlieg, J. J Med Chem, 2007, 50, 6507-6518.
Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I.N.; Bourne, P. E. Nucleic Acids Res, 2000, 28, 235-242.
Poulos, T. L.; Finzel, B. C.; Howard, A. J. J Mol Bio, 1987, 195, 87-700.
Raag, R.; Poulos, T. L. Biochemistry, 1989, 28, 7586-7592.
Wester, M. R.; Yano, J. K.; Schoch, G. A.; Yang, C.; Griffin, K. J.; Stout, C. D.; Johnson, E. F. J Biol Chem, 2004, 279, 35630-35637.
Yano, J. K.; Wester, M. R.; Schoch, G. A.; Griffin, K. J.; Stout, C. D.; Johnson, E. F., J Biol Chem, 2004, 279, 38091-38094.
Reynald, R. L.; Sansen, S.; Stout, C. D.; Johnson, E. F. J Biol Chem, 2012, 287, 44581-44591.
Schoch, G. A.; Yano, J. K.; Sansen, S.; Dansette, P. M.; Stout, C. D.; Johnson, E. F., J Biol Chem, 2008, 285, 17227-17237.
Pedretti, A.; Villa, L.; Vistoli, G. J Mol Graph Model, 2002, 21, 47-49.
Williams, P. A.; Cosme, J.; Ward, A.; Angove, H. C.; Vinkovi?, D. M.; Jhoti, H. Nature, 2003, 424, 464-468.
Gasteiger, J.; Marsili, M. Tetrahedron, 1980, 36, 3219-3228.
Hall, T. A. Nucleic Acids Symp Ser, 1999, 41, 95-98.
Humphrey, W.; Dalke, A.; Schulten, K. J Mol Graph M, 1996,
, 33-38.
Studio, D. , version 4.0, San Diego: Accelrys. Inc, 2009.
Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; Olson, A. J. J. Comput. Chem, 2009, 30, 2785-2791.
Vedani, A.; Huhta, D. W. J. Am. Chem. Soc, 1990, 112, 4759-4767.
Sirim, D.; Widmann, M.; Wagner, F.; Pleiss, J. BMC Struct. Biol, 2010, 10, 34-46.
Schoch, G. A.; Yano, J. K.; Wester, M. R.; Griffin, K. J.; Stout, C. D.; Johnson, E. F. J Biol Chem, 2004, 279, 9497-9503.
Whitford, D. Proteins: structure and function, Sussex: John Wiley & Sons, 2013.
Kaminsky, L. S.; Zhang, Z. Y. Pharmacol. Ther, 1997, 73, 67-74.
Ufer, M. Clin Pharmacokinet, 2005, 44, 1227-1246.
Ortiz de Montellano P. R. Chem Rev, 2010 110, 932-948.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
